FIELD: medicine; gastroenterology; oncology.
SUBSTANCE: invention is intended for the prevention and treatment of gastric ulcers and colon cancer. An oral suspension with antiulcer and chemoprotective effects for colon cancer is an aqueous suspension containing the following active ingredients: a purified extract of fatty alcohols from the purified wax of Apis mellifera bees and microcrystalline cellulose.
EFFECT: use of the invention provides strong antiulcer and chemoprotective effects due to the synergistic action of the components.
4 cl, 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL, POSSESSING A GASTROPROTECTIVE (ANTIULCER) ACTIVITY | 2016 |
|
RU2637644C1 |
| DEANOL ACEGLUMATE DEMONSTRATING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY, COMBINATION POSSESSING ANTIULCEROGENIC, GASTROPROTECTIVE AND ENTEROPROTECTIVE ACTIVITY (VERSIONS), PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2435575C2 |
| AGENT FROM CITRUS WASTE ELICITING ANTI-ULCER ACTIVITY | 2001 |
|
RU2262944C2 |
| ANTIULCER AGENT AND METHOD OF ITS PREPARING | 1998 |
|
RU2141332C1 |
| METHOD OF STOMACH AND DUODENUM ULCER TREATMENT | 2007 |
|
RU2357741C1 |
| ANTIULCER AGENT AND METHOD OF ITS PREPARING | 1996 |
|
RU2146936C1 |
| METHOD OF PREPARING THE AGENT SHOWING ANTIULCER ACTION | 1994 |
|
RU2086251C1 |
| METHOD FOR PREPARING AGENT POSSESSING ANTIULCEROGENIC ACTION | 2013 |
|
RU2533228C2 |
| METHOD FOR PREVENTION OF ULCERATION OF GASTRIC MUCOSA | 2020 |
|
RU2744455C1 |
| 3-[3-(MORPHOLINE-4-YL)PROPYL]-2-[(2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-YL)METHYL-1,3-THIAZOLIDINE-4-ONE WITH ANTI-ULCER AND ANTI-INFLAMMATORY ACTIVITY | 2017 |
|
RU2643669C1 |
